Fungal cell membrane component

Fungal cell membrane components primarily refer to the molecules that make up the plasma membrane of fungal cells. Unlike plant and animal cells, a major distinguishing feature of the fungal membrane is the presence of **ergosterol**, a sterol that serves a structural and regulatory role analogous to cholesterol in humans. The membrane also contains **glycerophospholipids** and **sphingolipids**, as well as a wide array of membrane proteins including transporters and enzymes regulating homeostasis, transport, and cell wall synthesis. Because of their chemical distinctiveness—especially the presence of ergosterol and unique sphingolipids—these components have emerged as **major targets for antifungal drugs**. Drugs such as amphotericin B bind ergosterol directly, forming pores that disrupt membrane integrity, while azole and allylamine classes inhibit steps in ergosterol biosynthesis, making the membrane dysfunctional. Fungal membrane components are not a single molecular entity but rather a class of related structures, and as such, this is an over-broad designation for a drug target; "Fungal cell membrane component" is not a specific canonical drug target, but rather refers to a set of molecular species used as drug targets or biomarkers[7]. Most antifungal agents that target the membrane do so by (a) direct structural disruption, (b) inhibiting sterol biosynthesis, or (c) modulating synthesis of wall components closely coordinated with membrane function[7][5]. The unique presence of ergosterol versus cholesterol provides specificity, but also poses off-target safety risks due to the presence of related sterols in human cells, and resistance concerns arise from membrane remodeling or modification[7]. Notes on correctness: - This entry ("Fungal cell membrane components") is *overly broad* and therefore is **not a canonical unique target**; it is a collection or class. For structured databases, targets should be mapped to specific, actionable components (such as ergosterol or biosynthetic enzymes like lanosterol 14-α-demethylase)[7]. - If you are seeking drug target annotations, use "Ergosterol" or a biosynthetic enzyme rather than the umbrella term "Fungal cell membrane component". - No common abbreviation. - Aliases are type-based, not standardized by a gene or protein symbol. - Relevant to antifungal pharmacology and medical mycology[7][5].

Other names

fungal plasma membrane componentfungal membrane lipidfungal sterolergosterol (for primary sterol species)fungal sphingolipid

membrane disruption (amphotericin B binds ergosterol and forms pores), inhibition of ergosterol synthesis (azoles inhibit lanosterol 14-α-demethylase; allylamines inhibit squalene epoxidase), inhibition of cell wall synthesis (echinocandins, which indirectly impact membrane–wall interactions)